Relmada Therapeutics, Inc. (RLMD): SCHEDULE 13G filed Jun 22, 2026

Form type
SCHEDULE 13G
Filing date
Jun 22, 2026
Accession number
0001104659-26-076490
Filer
Relmada Therapeutics, Inc. (CIK 1553643)